---
layout: default
title: Activated Charcoal Arabica Coffee Bean Causticum E
parent: 僅模型預測 (L5)
nav_order: 196
evidence_level: L5
indication_count: 0
---

# Activated Charcoal Arabica Coffee Bean Causticum E
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Component Herbal Formula: Insufficient Data for Repurposing Evaluation

## One-Sentence Summary

This submission describes a multi-component formula comprising eight ingredients — including Activated Charcoal, Arabica Coffee Bean, Causticum, Eleuthero, Glycyrrhiza Glabra, Prasterone, Ribes Nigrum Flower Bud, and Veratrum Album Root — with no approved indication on record in Taiwan.
The TxGNN model returned **no predicted new indications** for this compound entry, and **no supporting clinical trials or publications** were identified for evaluation.
Without a DrugBank anchor or a recognized INN-level identity, the evidence pipeline could not generate a scorable candidate.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | No approved indication on record |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (no supporting studies identified) |
| Market Status | Not marketed in Taiwan |
| Number of Approvals | 0 |
| Recommended Decision | Hold |

---

## Why No Prediction Was Generated

The TxGNN pipeline requires a resolvable DrugBank ID to anchor a drug within the knowledge graph. For this submission, the query string contained **eight heterogeneous ingredients** simultaneously, including:

- A physical adsorbent (Activated Charcoal)
- A botanical adaptogen (Eleuthero / *Eleutherococcus senticosus*)
- A licorice root extract (*Glycyrrhiza glabra*)
- A steroid hormone precursor (Prasterone / DHEA)
- Two homeopathic dilutions (Causticum, Veratrum Album Root)
- A berry bud extract (Ribes Nigrum Flower Bud)
- A caffeinated botanical (Arabica Coffee Bean)

This formulation does not correspond to a single recognized INN or a named fixed-dose combination registered in any major pharmacopoeia. As a result, **no DrugBank ID was resolved**, the knowledge graph could not assign a node, and TxGNN produced no output.

The combination also presents a pharmacological heterogeneity problem: the ingredients span at least four mechanistic classes (adsorption, hormonal modulation, adaptogenic activity, homeopathic dilution), making any unified mechanism-of-action analysis impractical with current tools.

---

## Clinical Trial Evidence

Currently no related clinical trials registered for this multi-component entry as a combined formulation.

---

## Literature Evidence

Currently no related literature available for this multi-component entry as a combined formulation.

---

## Safety Considerations

Please refer to the package insert for safety information.

> **Note for reviewers**: Veratrum album root contains steroidal alkaloids (jervine, cyclopamine) that are highly toxic in non-diluted forms. Even in homeopathic preparations, any formulation containing this ingredient should undergo a dedicated toxicological review before any repurposing assessment proceeds.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The evidence pipeline could not evaluate this submission because the multi-ingredient query string does not resolve to a single pharmacological entity; without a DrugBank node, TxGNN has no basis for prediction, and no existing indication or safety profile exists in the Taiwan registry.

**To proceed, the following is needed:**

- **Decompose the formula**: Submit each of the eight ingredients as separate, INN-level queries so the TxGNN pipeline can evaluate each component individually against the knowledge graph.
- **Establish a primary active ingredient**: Identify which ingredient is the therapeutic driver (e.g., Prasterone / DHEA or Glycyrrhiza glabra extract) and build the repurposing case around that single agent.
- **Resolve a DrugBank ID**: At minimum for Prasterone (DB01708), Eleuthero, and Glycyrrhiza glabra, which each have structured entries that support KG traversal.
- **Toxicological review for Veratrum Album**: Before any clinical or regulatory pathway is explored, an independent safety review of Veratrum album root content and dose is required.
- **Clarify regulatory classification**: Determine whether this formula is intended as a pharmaceutical drug, dietary supplement, or homeopathic product — this classification determines which regulatory and evidence framework applies.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

